Optison Perflutren Protein-Type A Microspheres 10 mg/mL

Optison Perflutren Protein-Type A Microspheres 10 mg/mL is an injectable solution used for contrast enhancement in ultrasound imaging. This product, manufactured by GE Healthcare Inc., is designed to improve the visibility of blood flow and cardiac structures during diagnostic procedures.

Optison Perflutren Protein-Type A Microspheres are primarily used as a contrast agent in ultrasound imaging. This medication helps to enhance the visibility of blood flow and cardiac structures, making it easier for healthcare professionals to diagnose and monitor various conditions. What is Optison used for? It is commonly employed in echocardiograms to provide clearer images of the heart and its function.

When administered intravenously, Optison Perflutren Protein-Type A Microspheres can help improve the clarity of ultrasound images. This enhancement allows for better visualization of blood flow and cardiac structures, aiding in the accurate diagnosis and monitoring of heart conditions. Common effects may include temporary improvements in image quality during the procedure.

Optison should be used under the supervision of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before administration. Proper handling and storage are crucial to maintain the efficacy and safety of the product.

Optison may interact with other medications or substances. It is advisable to discuss all current medications with a healthcare provider before using this contrast agent. Specific interactions with alcohol or other contrast agents should be considered to avoid potential complications.